體外受精 (IVF) 市場：2020-2026
In-Vitro Fertilization (IVF) Market 2020-2026
在預測期內，全球體外受精 (IVF) 市場預計將以約 9.6% 的高複合年增長率增長。試管嬰兒在醫療保健領域對不孕症的治療發揮著重要作用。這是一系列程序，用於預防遺傳問題和治療不孕症，同時支持受孕。體外受精包括在培養皿中混合雌性卵子和雄性精子並將它們移植到子宮中。體外受精有五個程序，包括藥物、卵子收集、受精、胚胎培養和胚胎移植。
體外受精的完整週期大約需要 3 週。這是為 40 歲以上有不孕症的女性推薦的主要治療方法。 IVF 可以通過兩種受精技術進行：授精和卵胞漿內單精子注射 (ICSI)。用於這種治療的設備包括專用顯微鏡、孵化器、超聲設備和試管嬰兒一次性用品。它可以為有排卵障礙、不明原因不孕症、子宮內膜異位症和子宮肌瘤等問題的人和他們的伴侶進行。
不孕症患病率的上升導致對 IVF 程序的需求增加，這推動了市場增長。此外，輔助生殖技術的增長趨勢和政府為改善生育治療的可及性所做的有利可圖的努力正在進一步推動市場增長。然而，有幾個因素限制了市場增長，例如與治療相關的高成本和與 IVF 治療相關的風險，如多胞胎、流產、卵子收集程序的併發症、早產、低體重和異位妊娠。有。然而，生育診所的擴張為市場增長提供了機會。
本報告探討了體外受精 (IVF) 市場，並按程序類型、產品、最終用戶、地區和進入市場的公司概況介紹了市場概況以及趨勢。
Global In-Vitro Fertilization (IVF) Market By Procedure Type (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, Embryo Banking), By Product (Reagents, Equipment, and Software), By End-User (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Others), Forecast Period 2021-2027
The global in-vitro fertilization (IVF) market is growing at a significant CAGR of nearly 9.6% during the forecast period. IVF plays a vital role in the health care sector for the treatment of infertility. It is a series of procedures that are used to prevent genetic problems and treat infertility while supporting the conception of a child. Under the IVF procedure, a woman's egg and a man's sperm are combined in a laboratory dish and then it is transferred to a uterus. There is five procedure involved in the IVF procedure such as medication, harvest the eggs, fertilization, embryo culture, and embryo transfer.
A full cycle of IVF can take about three weeks. It is a primary treatment that is suggested for women with infertility problem above the age of 40. IVF can be done by two fertilization techniques that are insemination and intracytoplasmic sperm injection (ICSI). The devices that are used for this treatment are the special microscope, incubators, ultrasound machines, IVF disposables and other such devices. It can be done if people and their partner have problems such as ovulation disorders, unexplained infertility, endometriosis, uterine fibroids, among other problems.
An increasing prevalence of infertility is leading to increasing demand for IVF procedure and thereby is driving the market growth. Additionally, the increasing trends of assisted reproductive technology and favorable government initiatives to increase the accessibility of infertility treatment are further driving the growth of the market. However, some factors are restraining the market growth include high cost associated with the treatment, and the risk associated with the IVF treatment such as multiple births, miscarriage, egg-retrieval procedure complications, premature delivery and low birth weight, and ectopic pregnancy, among others. However, the expansion of infertility clinics is offering an opportunity for market growth.
The market is segmented based on procedure type, product, and end-user. Based on procedure type, the market is segmented into the frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Based on the product, the market is segmented into reagents, equipment, and software. Based on the end-user, the market is segmented into hospitals and research laboratories, fertility clinics and surgical centers, and others.
Global IVF Market Share by End User, 2020 (%)
Source: OMR Global
Fertility Clinics and Surgical Centers to Witness Fastest Growth During the Forecast Period
Expansion of fertility clinics is one of the major factors resulting in a potential share of fertility clinics and surgical centers. Rising incidences of infertility have resulted in the expansion of fertility clinics and surgical centers. For instance, in November 2020, Nova IVF Fertility launched a new state-of-the-art IVF center in Kolkata, India. The center is led by highly qualified IVF specialists, trained embryologists, Global Standards and Protocols, the latest embryology lab, and a comprehensive range of fertility solutions. Other major fertility clinics focusing on the expansion of their centers globally include IntegraMed America, Inc. and Western Fertility Institute.
The market is analyzed based on geographical regions such as North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the major markets for IVF treatment globally. Rising incidences of infertility and rising medical tourism are some factors accelerating the demand for IVF treatment across Europe. As per the Fertility Europe VZW data published in October 2020, over 25 million citizens are affected by infertility across Europe. Additionally, significant focus on advanced technologies and the availability of IVF treatment at low cost are some of the major causes that are surging the market growth in Europe.
Global IVF Market Growth by Region, 2021-2027
Source: OMR Global
Asia-Pacific is Expected to Witness Potential Share in the Market During the Forecast Period
Asia-Pacific is estimated to be the fastest-growing market during the forecast period. Several factors are driving the growth of the market such as increasing ovulation disorder in women, increasing trends of assisted reproduction technology, and increasing rate of infertility. Additionally, government initiatives for fertility treatment are expected to offer an opportunity for market growth. For instance, in November 2017, the Telangana government (Indian state) declared that it will start fertility centers at government hospitals to increase the accessibility of infertility treatment among couples. This, in turn, is expected to further drive the market growth in the region.
Market Players Outlook
Key players operating in the market include CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. To survive in the market, these market players adopt different marketing strategies such as merger and acquisitions, product launches, and geographical expansion to expand their market share. For instance, in February 2021, TMRW Life Sciences declared that it has launched the world's first automated cryo specimen management solution for embryos and eggs used in IVF. TMRW's proprietary platform has been installed in multiple premier fertility clinics in the US, launching the modern era of integrated, software-enabled management of the millions of eggs and embryos central to modern IVF. The company is expanding globally and declared that it will be in UK-based fertility clinics in the summer of 2021.
The Report Covers
Market value data analysis of 2020 and forecast to 2027.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global IVF market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.